Table 2.
Characteristic | Tivozanib | Sorafenib |
---|---|---|
MW | 454.863 | 464.824 |
VEFR1 IC50 | 0.21 nmol/L | 26 nmol/L |
VEFR2 IC50 | 0.16 nmol/L | 90 nmol/L |
VEFR3 IC50 | 0.24 nmol/L | 100 nmol/L |
2-D Structure | ||
3-D Structure |
Characteristic | Tivozanib | Sorafenib |
---|---|---|
MW | 454.863 | 464.824 |
VEFR1 IC50 | 0.21 nmol/L | 26 nmol/L |
VEFR2 IC50 | 0.16 nmol/L | 90 nmol/L |
VEFR3 IC50 | 0.24 nmol/L | 100 nmol/L |
2-D Structure | ||
3-D Structure |